These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 16889570)
1. Novel renoprotective actions of erythropoietin: new uses for an old hormone. Johnson DW; Forman C; Vesey DA Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Sharples EJ; Thiemermann C; Yaqoob MM Nat Clin Pract Nephrol; 2005 Dec; 1(2):87-97. PubMed ID: 16932374 [TBL] [Abstract][Full Text] [Related]
4. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan. Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin: a hormone with multiple functions. Lombardero M; Kovacs K; Scheithauer BW Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975 [TBL] [Abstract][Full Text] [Related]
6. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Jelkmann W; Wagner K Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761 [TBL] [Abstract][Full Text] [Related]
7. [Physiology of eryhtropoietin and its therapeutic use]. Casadevall N Ann Pharm Fr; 1996; 54(4):151-6. PubMed ID: 8881101 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. van der Putten K; Braam B; Jie KE; Gaillard CA Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction? Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-- measurement and clinical applications. Marsden JT Ann Clin Biochem; 2006 Mar; 43(Pt 2):97-104. PubMed ID: 16536911 [TBL] [Abstract][Full Text] [Related]
11. The interaction between heart failure and other heart diseases, renal failure, and anemia. Silverberg DS; Wexler D; Iaina A; Schwartz D Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection. Fliser D; Haller H Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185 [TBL] [Abstract][Full Text] [Related]
13. Cellular protection by erythropoietin: new therapeutic implications? Joyeux-Faure M J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240 [TBL] [Abstract][Full Text] [Related]
15. Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect? Sturiale A; Campo S; Crascì E; Aloisi C; Buemi M Ren Fail; 2007; 29(3):379-86. PubMed ID: 17497457 [TBL] [Abstract][Full Text] [Related]